ExpreS2ion Biotech Holding AB (EXPRS2) — Tangible Net Worth Ratio
ExpreS2ion Biotech Holding AB (EXPRS2) has a Tangible Net Worth Ratio of 95.8% as of December 2025. This metric is calculated by deducting intangible assets (Skr1.50 Million) from net assets (Skr35.69 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ExpreS2ion Biotech Holding AB short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
ExpreS2ion Biotech Holding AB Tangible Net Worth Ratio (2013–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Tangible Net Worth Ratio has changed across 11 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 95.8%, reflecting net assets of Skr35.69 Million with intangible assets of Skr1.50 Million SEK. See EXPRS2 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for ExpreS2ion Biotech Holding AB (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for ExpreS2ion Biotech Holding AB from 2013 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see EXPRS2 market cap overview.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.8% | Skr35.69 Million | Skr1.50 Million | Skr65.11 Million | ▼ -1.0 pp |
| 2024 | 96.8% | Skr64.42 Million | Skr2.08 Million | Skr104.53 Million | ▲ +0.6 pp |
| 2023 | 96.2% | Skr65.36 Million | Skr2.47 Million | Skr78.69 Million | ▼ -0.9 pp |
| 2022 | 97.1% | Skr103.33 Million | Skr2.95 Million | Skr137.36 Million | ▼ -0.6 pp |
| 2021 | 97.8% | Skr140.35 Million | Skr3.14 Million | Skr151.96 Million | ▲ +1.9 pp |
| 2020 | 95.9% | Skr94.55 Million | Skr3.91 Million | Skr118.86 Million | ▲ +80.6 pp |
| 2018 | 15.3% | Skr8.30 Million | Skr7.03 Million | Skr20.95 Million | ▲ +37.6 pp |
| 2017 | -22.3% | Skr6.74 Million | Skr8.24 Million | Skr17.23 Million | ▼ -48.9 pp |
| 2016 | 26.5% | Skr12.88 Million | Skr9.46 Million | Skr24.61 Million | ▼ -73.5 pp |
| 2014 | 100.0% | Skr2.35 Million | Skr0.00 | Skr5.48 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr1.93 Million | Skr0.00 | Skr4.11 Million | — |